Trial Profile
Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effect of KQ-791 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2019
Price :
$35
*
At a glance
- Drugs KQ 791 (Primary)
- Indications Insulin resistance
- Focus Adverse reactions
- Sponsors Kaneq Bioscience
- 05 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Mar 2015 New trial record